Amendment and Mail Process Complete

OCTIQ

Innovus Pharmaceuticals, Inc.

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88179843 FILING DATE 11/02/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY HELMERS, SARA A
L.O. ASSIGNED N80-NOT FOUND

PUB INFORMATION

RUN DATE 10/08/2019
PUB DATE 04/02/2019
STATUS 686-PUBLISHED FOR OPPOSITION
STATUS DATE 10/07/2019
LITERAL MARK ELEMENT OCTIQ

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT OCTIQ
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Innovus Pharmaceuticals, Inc.
ADDRESS 8845 Rehco Road
San Diego, CA 92121
ENTITY 03-CORPORATION
CITIZENSHIP Nevada

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Non-medicated eye drops and non-medicated lubricating solutions for the eyes, to be sold over the counter, without a prescription; over-the-counter, non-prescription pharmaceutical preparations for the treatment of cataracts; none of the foregoing for use in the treatment of pain

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
10/05/2019 CHPB I CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED 013
10/04/2019 APET A ASSIGNED TO PETITION STAFF 012
09/26/2019 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED 011
09/05/2019 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED 010
08/16/2019 DOCK D ASSIGNED TO EXAMINER 009
04/24/2019 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED 008
04/02/2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 007
04/02/2019 PUBO A PUBLISHED FOR OPPOSITION 006
03/13/2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 005
02/18/2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 004
02/07/2019 DOCK D ASSIGNED TO EXAMINER 003
11/18/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
11/06/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Randy Berholtz
CORRESPONDENCE ADDRESS Randy Berholtz
8845 REHCO ROAD
Legal
SAN DIEGO, CA 92121
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Innovus Pharmaceuticals, Inc.
ADDRESS 8845 Rehco Road
San Diego, CA 92121
ENTITY 03-CORPORATION
CITIZENSHIP Nevada

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed